Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
54
Number of overlapping holdings
88.5%
% of BBP's 65 holdings also in IBB
24.2%
% of IBB's 260 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 8.6% | 2.1% |
|
AMGEN INC | 2.0% | 8.4% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 9.6% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 3.5% | 1.6% |
|
BIOGEN IDEC INC | 1.6% | 2.1% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to IBB
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
SAGE THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.0% |
|
SPRINGWORKS THERAPEUTICS, INC. | 1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 1.7% |
|
DYNAVAX TECHNOLOGIES CORP | 1.7% |
|
LIGAND PHARMACEUTICALS-CL B | 1.7% |
|
ARDELYX INC | 1.7% |
|
AXSOME THERAPEUTICS, INC. | 1.6% |
BBP Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -7.8% |
|
AMGEN INC | -6.5% |
|
GILEAD SCIENCES INC | -6.5% |
|
REGENERON PHARMACEUTICALS | -5.7% |
 |
ARGENX SE ADR | -3.1% |
|
IQVIA HOLDINGS INC | -3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | -2.5% |
|
WATERS CORP | -2.3% |
|
NATERA INC | -2.3% |
|
ALNYLAM PHARMACEUTICALS INC | -1.9% |